FindTrial
Sign In

Cost analysis in treatment of Gynecological Cancer

Estimation of Out of Pocket Expenditure by patients in Pre-treatment evaluation of Gynaecological Cancer: A Cross-Sectional Observational Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/070008
Enrollment
200
Registered
2024-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C530- Malignant neoplasm of endocervix Health Condition 2: C541- Malignant neoplasm of endometrium Health Condition 3: C510- Malignant neoplasm of labium majus Health Condition 4: C569- Malignant neoplasm of unspecifiedovary Health Condition 5: C574- Malignant neoplasm of uterine adnexa, unspecified Health Condition 6: C55- Malignant neoplasm of uterus, partunspecified Health Condition 7: C52- Malignant neoplasm of vagina

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

UCMS and GTB Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: SUSPECTED/ DIAGNOSED GYNAECOLOGIC CANCER (CERVIX, UTERUS, OVARY,VAGINA, VULVA)

Exclusion criteria

Exclusion criteria: NON-GYNAECOLOGIC MALIGNANCIES

Design outcomes

Primary

MeasureTime frame
Out-of-pocket expenditure(direct & indirect) Timepoint: baseline—

Secondary

MeasureTime frame
Catastrophic Health Expenditure RateTimepoint: baseline—

Countries

India

Contacts

Public ContactDr Nazia Parveen

UCMS and GTB Hospital

nazmamc@gmail.com9873617784

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026